In addition, given the obligatory requirement of SHP2 in signaling pathways mediated by receptor tyrosine kinases, many of which are up-regulated in melanoma, SHP2 may also be required for melanoma pathogenesis and progression. This evidence concerns the gene NTRK1 and melanoma.